International Cancer Institute

Cancer Care, Research Training & Education

Home CPR ICI CANCER PREVENTION AND CONTROL PRECEPTORSHIP

CPR ICI Cancer Prevention and Control Preceptorship

A multidisciplinary course on the principles and practice of cancer prevention.

Eldoret, Kenya

 

Training Duration:  6 weeks

Course Director: Prof. Fredrick Chite Asirwa MD

Consultant Physician. Medical Oncologist & Hematologist Executive

Director/CEO: International Cancer Institute (ICI)

P.O. Box 8088, Code 30100 Eldoret, Kenya

Email: director@intercancer.com Website: www.intercancer.com

 

Course Coordination: Dr. Kevin Makori

Head, Office of Education and Training

International Cancer Institute (ICI)

P.O. Box 8088, Code 30100 Eldoret, Kenya

Email:  kevin.makori@intercancer.com Website: www.intercancer.com

 

This educational activity is provided independently by International Cancer Institute (ICI) through the Blueprint Program

 

ICI Education & Training Mission Statement

 

The ICI Preceptorship Program Mission is to measurably contribute to cancer patients’ (and populations) safety and health outcomes and to support practice improvement by providing CME/CPD activities that enhance the ability of physicians and other healthcare team members to deliver quality and optimal healthcare services.

 

Purpose

 

The purpose of ICI Preceptorship Program is to develop educational activities that clearly link the needs of the learner/participants with the planning process, format and delivery of each activity, resulting in high- quality Continuing Medical Education (CME)/Continued Professional Development (CPD) opportunities that will increase the knowledge, competence, and performance of health-care providers and translate into impactful population outcomes.

 

Target Audience

 

The primary target audience for this CPR 100 Course comprises public health professionals, physicians, and other healthcare professionals, research & clinical residents/fellows, policymakers, and scientists who have an interest in cancer prevention and control.

 

Statement of Need

 

Information on Prevention and Methods of prevention of cancers are not often widely disseminated, especially in sub-Saharan Africa, resulting in populations not receiving the best or most up-to-date information on the preventative aspects of cancers. Health care providers need current information on prevention strategies that are the cornerstone of any cancer control program.

 

This course will present a broad-based perspective in cancer prevention and control including resources, data, methods, and theories. Participants will be exposed to classical cancer epidemiology concepts in the cancer continuum (etiology, prevention, screening, diagnosis, treatment, including palliative care, and survivorship), as well as cross-cutting concepts such as cancer surveillance, epidemiology methods, and communication that are critical to the success of any cancer prevention and control activity

LEARNING OBJECTIVES

At the end of this educational activity, participants should be able:

  1. To describe the global burden of cancer, including country and regional differences while comparing and contrasting the cancer burden in different regions in the world vs Sub-Saharan Africa
  2. To understand the importance of cancer surveillance and the role of cancer registries to determine the burden and distribution of cancer in different regions and populations.
  3. Understand the importance of multidisciplinary approaches to cancer prevention and the role of the National Cancer Control Programs/ National Cancer Institutes in Cancer Prevention. Participants should also be able to Articulate the role and contribution of different disciplines to cancer prevention and control
  4. To describe the role of key lifestyle factors in the etiology of cancer, as well as approaches to cancer prevention.
  5. To understand the role that occupational and environmental exposures play in the etiology of certain cancers, as well as preventive measures.
  6. To understand the principles of clinical cancer prevention with a special emphasis on chemoprevention and future directions in the field.
  7. To describe the cancer epidemiology and interpret current information on the descriptive epidemiology, etiology, screening, and early detection of some of the major cancers, as well as identify and adapt early detection methods for site-specific tumors.
  8. Assess the strengths and weaknesses of the three main approaches to cancer prevention (primary, secondary, and tertiary) in general, and then relative to a specific country setting
  9. Categorize advantages and disadvantages of all the current cancer screening methods
  10. Discuss approaches and methods that can be used to adapt existing U.S. guidelines and evidence-based approaches in cancer prevention and control to different countries/settings
  11. To design and present primary prevention case study working in multidisciplinary team. Participants will also be able to list key concepts critical to designing basic implementation and/or dissemination science project. Finally, participants will be able to describe health communication tools in cancer prevention and control that target various stakeholders.
  12. To be able to describe low-budget approach to improve screening among disadvantaged and/or hard-to-reach communities.

Disclosure of Conflicts of Interest

 

International Cancer Institute (ICI) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ICI for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

 

The faculty must report any financial relationships or contractual relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.

 

Disclaimer

 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

 

Disclosure of Unlabeled Use

 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

 

Method of Participation and Request for Credit

 

To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures, and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

 

THE COURSE LECTURES & DISCUSSIONS

Orientation to the course 

  1. Introduction to Cancer Prevention 
  2. Diet/ nutrition and cancer prevention
  3. Physical activity and cancer prevention
  4. Tobacco exposure/ smoking cessation
  5. Psychosocial Health and well-being in cancer prevention
  6. Cancer Genetics Risk Testing
  7. Breast Cancer Prevention 
  8. Colorectal Cancer prevention
  9. Cancer Prevention in hard-to-reach populations
  10. Secondary cancer prevention and cancer survivorship
  11. Primary prevention: Occupational & Environmental Risk Factors
  12. Behavioral Science and Community Interventions
  13. Human and Economic benefits of Cancer Prevention 
  14. Radiation Exposure and Cancer Risk
  15. Cancer Prevention Clinical Trials and Future Research
  16. Communication, Advocacy, and policy inn cancer prevention

 

All those interested in registering for this course, please register your information on www.elearning.intercancer.com  if you have any questions or queries please send an email to education@intercancer.com or director@intercancer.com

 

For more information visit our website www.intercancer.com

 

International Cancer Institute (ICI) ©2022

Your Partner in Cancer Control in SSA

CPR102 ICI Cancer Prevention Preceptorship

KSh2,000.00KSh20,000.00

SKU: N/A Category: Tag:

Description

Subscribing to the course

You can purchase the entire course for Ksh. 20,000.00 ($200) or purchase individual units at Ksh. 2,000.00 ($20).

  • Introduction to Cancer Prevention
  • Diet/ nutrition and cancer prevention
  • Physical activity and cancer prevention
  • Tobacco exposure/ smoking cessation
  • Psychosocial Health and well-being in cancer prevention
  • Cancer Genetics Risk Testing
  • Breast Cancer Prevention
  • Colorectal Cancer Prevention
  • Cancer Prevention in hard-to-reach populations
  • Secondary cancer prevention and cancer survivorship
  • Primary prevention: Occupational & Environmental Risk Factors
  • Behavioral Science and Community Interventions
  • Human and Economic benefits of Cancer Prevention
  • Radiation Exposure and Cancer Risk
  • Cancer Prevention Clinical Trials and Future Research
  • Communication, Advocacy, and policy in cancer prevention

Additional information

CPR

Introduction to Cancer Prevention, Diet/ nutrition and cancer prevention, Physical activity and cancer prevention, Tobacco exposure/ smoking cessation, Psychosocial Health and well-being in cancer prevention, Cancer Genetics Risk Testing, Breast Cancer Prevention, Colorectal Cancer prevention, Cancer Prevention in hard-to-reach populations, Secondary cancer prevention and cancer survivorship, Primary prevention: Occupational & Environmental Risk Factors, Behavioral Science and Community Interventions, Human and Economic benefits of Cancer Prevention, Radiation Exposure and Cancer Risk, Cancer Prevention Clinical Trials and Future Research, Communication, Advocacy, and policy inn cancer prevention, Full Course

International Cancer Institute